drugset / Trial / NCT03081806
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Knee Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase 3, Multicenter, 22-Week, double-blind and 30-Week open label Study to Evaluate the Efficacy and Safety of X0002 Spray in relief of pain of subjects with Osteoarthritis of the Knee.
Timeline
- Start
- 2021-09-24
- Primary completion
- 2024-01-10
- Completion
- 2024-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IBUPROFEN TRELAMINE | Small molecule | — | — |